AzTrials
AzTrials

Morbid ObesityNCT01105156

Outcomes of Gastric Band Fills as Found With a Patient Self-reported Questionnaire: The Vomiting, Eating, and Weight Loss (VEW) Questionnaire

An observational study of Morbid Obesity, run by North Eastern Weight Loss Surgery at 1 site in Australia.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

1. Background / Scientific Rationale The VEW (Vomiting, Eating, and Weight Loss) Questionnaire has been developed as a method for the assessment of post bariatric surgery patients, as well as a research tool into the eating behaviour of these patients. Read more about this study

Who is it for?
Ages 16 to 70 years
Conditions the study is for
Morbid Obesity
What is being tested?
VEW Questionnaire
How many people
361 participants
Where
1 siteAustralia
Study dates
Apr 2010to Apr 2010
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 16 to 70 years
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: All patients who have received a Swedish Adjustable Gastric band at North Eastern Weight Loss Surgery

Who may be able to join

  • Patients who have received a Swedish Adjustable Gastric gastric band

Who cannot join

  • Patients who haven't received a Swedish Adjustable Gastric Band

Trial locations and contacts

1 site in 1 country.

Australia1 site
  • North Eastern Weight Loss Surgery

    Melbourne, Victoria, 3128

Other trials in Australia

About this study

Official title: Outcomes of Gastric Band Fills as Found With a Patient Self-reported Questionnaire. The VEW [Vomiting, Eating, and Weight Loss] Questionnaire

  1. Background / Scientific Rationale

The VEW (Vomiting, Eating, and Weight Loss) Questionnaire has been developed as a method for the assessment of post bariatric surgery patients, as well as a research tool into the eating behaviour of these patients.

Read more

Objective VEW Questionnaire Premise If used optimally the VEW score is a valuable tool for patients who have had Laparoscopic Gastric Band Surgery (LAGB). The VEW score will be able to assist clinicians treating patients with a LAGB, specifically the Swedish Adjustable Gastric Band (SAGB), by providing them a tool to enhance patient outcomes. By using the information gained from the VEW questionnaire we can assess many areas of the eating behavior, and adjustment outcomes in patients with Gastric Bands.

Hypotheses:

  • The VEW questionnaire aids in the assessment of the need for gastric band adjustment (up or down in volume)
  • Comparison of patient factors in those who have had a
  1. good outcome (increased weight loss)
  2. bad outcomes (vomiting, low weight loss, maladaption), from a gastric band fluid addition
  • In patients who have had a bad outcome, which factors are more predictive?
  • Fewer Complications associated with Gastric Band Adjustments
  • Obstruction
  • Need for urgent deflation
  • Pain on eating
  • Lowering incidence of inappropriate fills
  • Lower incidence of maladaption
  • Eating behavior can predict long term outcomes
  • By comparison of factors in the different quartiles of weight loss (particularly top 25% cf. bottom 25%)
  • Maintenance of weight loss after 12 months is best achieved by use of behavior modification via improved food tolerances and better eating behavior than by increasing restriction of the band by further adjustments. 12 months is chosen as an arbitrary time where the majority of expected weight loss (45% of expected 50-55% 0f EWL) has been achieved. It is also a time frame by which patients have learnt to use the band appropriately, and the gastric band has had time to be adjusted into its optimal range.
  • The VEW questionnaire can help predict poor outcomes from a SAGB adjustment.
  • By analyzing the factors in patients who have returned both acutely (days) or at subsequent visits (weeks) and had fluid removed from their bands. These factors would include pain, vomiting, length of meals, maladaption score, fluid added, etc.
Read the detailed description
  1. Background / Scientific Rationale

The VEW (Vomiting, Eating, and Weight Loss) Questionnaire has been developed as a method for the assessment of post bariatric surgery patients, as well as a research tool into the eating behaviour of these patients.

Objective VEW Questionnaire Premise If used optimally the VEW score is a valuable tool for patients who have had Laparoscopic Gastric Band Surgery (LAGB). The VEW score will be able to assist clinicians treating patients with a LAGB, specifically the Swedish Adjustable Gastric Band (SAGB), by providing them a tool to enhance patient outcomes. By using the information gained from the VEW questionnaire we can assess many areas of the eating behavior, and adjustment outcomes in patients with Gastric Bands.

Hypotheses:

  • The VEW questionnaire aids in the assessment of the need for gastric band adjustment (up or down in volume)
  • Comparison of patient factors in those who have had a
  1. good outcome (increased weight loss)
  2. bad outcomes (vomiting, low weight loss, maladaption), from a gastric band fluid addition o In patients who have had a bad outcome, which factors are more predictive?
  • Fewer Complications associated with Gastric Band Adjustments o Obstruction o Need for urgent deflation
  • Pain on eating
  • Lowering incidence of inappropriate fills
  • Lower incidence of maladaption
  • Eating behavior can predict long term outcomes
  • By comparison of factors in the different quartiles of weight loss (particularly top 25% cf. bottom 25%)
  • Maintenance of weight loss after 12 months is best achieved by use of behavior modification via improved food tolerances and better eating behavior than by increasing restriction of the band by further adjustments. 12 months is chosen as an arbitrary time where the majority of expected weight loss (45% of expected 50-55% 0f EWL) has been achieved. It is also a time frame by which patients have learnt to use the band appropriately, and the gastric band has had time to be adjusted into its optimal range.
  • The VEW questionnaire can help predict poor outcomes from a SAGB adjustment.
  • By analyzing the factors in patients who have returned both acutely (days) or at subsequent visits (weeks) and had fluid removed from their bands. These factors would include pain, vomiting, length of meals, maladaption score, fluid added, etc.
  1. Study Population, including Inclusion/Exclusion There are 507 patients that are eligible for inclusion to this study. The patients that will be included are only those patients that are eligible for a LAGB adjustment (thus excluding preoperative and the first post-operative visit) and have presented for review by the treating surgeon (single surgeon) in the year 2009. All non-gastric band and non-SAGB gastric bands have been excluded. Assessments by dietitians and psychologists have also been excluded.
  2. Study Procedures Initial Patient consent for the VEW questionnaire is obtained in consultation with the treating surgeon and dietician where the expectation, benefits and knowledge are explained and confirmed. This occurs prior to the need for adjustments, that is, during the preoperative period. To date there have been no patients that have not participated with the questionnaire.

The VEW questionnaire is handed out to all eligible (please see description for eligibility in point three) upon arrival to the clinic. Patients are given five minutes to fill out the questionnaire which is then brought into the consultation with them.

Patient care and treatment is done with the strictest adherence to the Declaration of Helsinki and in the aim of developing new and better guidelines for Best Practice for the treatment of patients who have had a LAGB.

  1. Duration of Study Twelve months starting 1st January 2009-31st December 2009.
  2. Procedure Type

The VEW score study is limited to patients that have had LAGB specifically the Swedish Adjustable Gastric Band (SAGB):

  • SAGB -VC
  • SABG -QC
  • SAGB - 2100 The VEW questionnaire is used following all bariatric procedures but the study would be limited to the above subset of patients.
  1. Primary / Secondary Safety and Efficacy Endpoints

Primary Efficacy Endpoints:

  • Optimal gastric band adjustment tailored for the patient for no pain on eating, no obstructions and urgent deflation of the band
  • Inappropriate adjustment of the LAGB
  • Identify and Decrease the incidence of maladaptive eating behaviours

Secondary Efficacy Endpoints:

  • Excess Weight loss at 3, 6, 12 months
  • Eating behaviour at 3,6,12 months
  • Incidence of Vomiting
  • Fill frequency and outcome
  1. Statistical Analysis Plan

Due to the significant amount of data that is currently contained in the North Eastern Weightloss Surgery database I have decided to narrow the parameters to the following for this particular study:

  • All patients will be broken into two arms, one control arm and one trial arm.
  • The outcomes that will be looked for are:
  1. Number of adjustments per patient
  2. Efficacy of the adjustments
  3. Excess Weight Loss (EWL)
  4. Eating behaviour and its changes
  5. Food tolerances (as per the Moore-Bohn Food tolerance scale)
  6. Safety Considerations and Reporting There are no safety considerations relating tho the use of the VEW questionnaire
Conditions
Morbid Obesity
Being tested
VEW Questionnaire
Keywords
Gastric band, Questionnaire, Post operative management, Adjustment
Medical subject headings
Obesity, Morbid

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • VEW QuestionnaireBehavioural

    Also called NEWLS Questionnaire

    Patient Self reported questionnaire filled in.

Study groups in NCT01105156
Study groupRoleWhat they receive
Gastric Band PatientsNot described
Receives: Behavioral: VEW Questionnaire

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Weight Loss

    Measured: 1 year

Secondary outcomes (3)
  1. Vomiting Frequency

    Measured: 12 months

  2. Maladaptive eating

    Evaluation of any change in dietary habits

    Measured: 12 months

  3. Gastric Band adjustments

    Number of adjustments

    Measured: 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Apr 2010 (estimated)
  2. Study startApr 2010
  3. Primary completionApr 2010 (estimated)
  4. Study completionApr 2010 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Retrospective
Enrolment
361 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01105156
Sponsor's protocol ID
NEWLS29401
Status last verified
Apr 2010
First submitted
13 Apr 2010
Last updated
16 Apr 2010
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

An observational study of Morbid Obesity, run by North Eastern Weight Loss Surgery at 1 site in Australia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 16 Apr 2010. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Australia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Weight Loss (time frame: 1 year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Apr 2010.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in